Page last updated: 2024-11-06

5-methoxysalicylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-methoxysalicylic acid: enhances intestinal absorption of insulin in rats; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-methoxysalicylic acid : A methoxysalicylic acid that is salicylic acid which is carrying a methoxy group at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID75787
CHEMBL ID452949
CHEBI ID89830
SCHEMBL ID128781
MeSH IDM0103404

Synonyms (55)

Synonym
AC-2987
6-hydroxy-m-anisic acid
6-methoxy-m-anisic acid
2-hydroxy-5-methoxy-benzoic acid
nsc 2579
einecs 220-037-8
ai3-24048
acid5-methoxysalicylic
5-methoxysalicylic acid
m-anisic acid, 6-hydroxy-
benzoic acid, 2-hydroxy-5-methoxy-
2-hydroxy-5-methoxybenzoic acid
5-methoxy-2-hydroxybenzoic acid
nsc2579
nsc-2579
2612-02-4
5-o-methyl gentisic acid
inchi=1/c8h8o4/c1-12-5-2-3-7(9)6(4-5)8(10)11/h2-4,9h,1h3,(h,10,11
2-hydroxy-5-methoxybenzoic acid, 98%
chebi:89830 ,
CHEMBL452949
M1254
AKOS000121285
2-hydroxy-5-methoxybenzoate
STK522179
BBL012998
6-methoxy-m-anisate
FT-0600625
S6319
5-methoxy-salicylic acid
2-hydroxy-5-(methyloxy)benzoic acid
5-methoxysalicyclic acid
2-hydroxy 5-methoxybenzoic acid
SCHEMBL128781
mfcd00002459
SY003499
DTXSID0062551
W-107199
AC-16957
CS-W007856
I12079
5-meosa
6-hydroxy-m-anisate
5-methoxy-2-hydroxybenzoate
5-methoxysalicylate
2-hydroxy-5-methoxybenzoicacid
HY-W007856
5-methoxy-2-hydroxobenzoic acid
AS-14602
Q15410212
AMY18253
5-methoxysalicylic acid 2-hydroxy-5-methoxybenzoic acid
EN300-21328
PD123981
Z104495362

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Microenema formulations containing 4% gelatin showed the highest insulin bioavailability of the formulations studied whereas microenemas (without gelatin) and suppository formulations were not as effective in enhancing the rectal absorption of insulin."( Enhancement of rectal absorption of insulin using salicylates in dogs.
Caldwell, L; Higuchi, T; Kamada, A; Nishihata, T; Routh, M; Rytting, JH, 1983
)
0.27
" Rectal bioavailability was quantitated by direct comparison of pharmacological effect with intravenous dose response."( Enhanced rectal bioavailability of polypeptides using sodium 5-methoxysalicylate as an absorption promoter.
Caldwell, L; Higuchi, T; Yoshioka, S, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methoxysalicylic acidA monohydroxybenzoic acid that is salicylic acid which carries a methoxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1145614Dissociation constant, pKa of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID338335Antiplatelet activity against rat platelet rich plasma assessed as inhibition of arachidonic acid-induced platelet aggregation at 0.25 mg/ml pretreated 2 mins before arachidonic acid challenge
AID1145616Increase in membrane potential in mollusc neurons assessed as conductance of potassium at pH 7.8 relative to salicylic acid1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145615Dissociation constant, pKa of the compound at pH 7.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145607Octanol-aqueous phase distribution coefficient, log D of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145605Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID338336Antiplatelet activity against rat platelet rich plasma assessed as inhibition of collagen-induced platelet aggregation at 0.25 mg/ml pretreated 2 mins before collagen challenge
AID1252320Antioxidant activity assessed as DPPH free radical scavenging activity at 0.01 to 1 mM after 30 mins2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
The antioxidant properties of salicylate derivatives: A possible new mechanism of anti-inflammatory activity.
AID338339Antiplatelet activity against rat platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation at 1 mg/ml pretreated 2 mins before ADP challenge
AID1090826Antifeedant activity against Hylobius abietis (pine weevil ) in compound pre-treated Scots pine twig at 50 mM measured after 24 hr by two-choice laboratory bioassay2007Journal of agricultural and food chemistry, Nov-14, Volume: 55, Issue:23
Quantitative structure-activity relationships of pine weevil antifeedants, a multivariate approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (57.89)18.7374
1990's1 (5.26)18.2507
2000's3 (15.79)29.6817
2010's4 (21.05)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.00 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]